This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Dec. 18, 2012




















 



Adherence disparities to hypertension meds may be reduced by low copays, mail-order pharmacies
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
New research suggests that making prescription refills more affordable and easier to get may reduce disparities among hypertension patients. An analysis of more than 44,000 patients recently diagnosed with high blood pressure in Kaiser Permanente Northern California identified important differences in medicine-taking behaviors among racial and ethnic groups. Lower copayments and the use of mail-order pharmacy increased refills of blood pressure medicine, and these factors were associated with reduced disparities. More



 Area and Association News


Tdap in pregnancy
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article

The Arizona Immunization Program Office of the Department of Health Services has been receiving a lot of questions about Tdap in pregnancy. There have been multiple changes on recommendations — the most recent is for every woman to get Tdap during each pregnancy. Below are a few links sent to practitioners.

VFC statement on pregnant adolescents getting Tdap — from October 2012 See #7 — even pregnant teenagers need Tdap. Link.

Most recent published MMWR recommendations on Tdap in pregnancy, Oct. 21, 2011 issue: Link. If a pregnant woman has not received Tdap, she should receive Tdap during pregnancy preferably during the third trimester or late second trimester after 20 weeks gestation.

Provisional ACIP recommendations page reflecting ACIP's voting in October 2012 meeting: Link.

All pregnant women should receive with Tdap WITH EACH PREGNANCY with the optimal time being 27-36 weeks gestation: Link.


Register today for the AzPA Psychiatric Certificate Program
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Assessing, Monitoring, and Managing Patients with Psychiatric Disorders: Comprehensive Medication Therapy Management to Optimize Pharmaceutical Care Learn more.


Inaugural Southwest Pharmacy Symposium
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Become a Pharmacy A.C.E. — Advocate, Communicate, Educate. Saturday, Jan. 26, 2013. Learn more.


Shop Amazon.com and support AzPA
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Will you be shopping online at Amazon.com this holiday season? Bookmark the AzPA Amazon Affiliates page, and a portion of your purchases will be donated to AzPA.

Holiday shopping is upon us
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Remember to purchase your gift cards through AzPA and support pharmacy education in Arizona. Learn more.


Not an AzPA member? Join today
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry. More

 Pharmacy Updates


Regulators faulted for inadequate compounding pharmacy oversight
American Society of Health-System Pharmacists    Share    Share on FacebookTwitterShare on LinkedinE-mail article
During hearings in November, Congress faulted lapses in state and federal oversight of pharmacy compounding that might have contributed to the meningitis outbreak associated with allegedly tainted drugs produced by the New England Compounding Center of Framingham, Mass. "The facts that we've uncovered so far in this investigation reveal frightening failures on multiple levels," said Colorado Rep. Diana DeGette during a Nov. 14 hearing of the House Energy and Commerce Committee's subcommittee on oversight and investigations. More

President Bill Clinton addresses health-system pharmacists
Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
President Bill Clinton addressed more than 20,000 health-system pharmacists on Dec. 3 as the keynote speaker at the opening session of the American Society of Health-System Pharmacists Midyear Clinical Meeting and Exhibition in Las Vegas. In his speech, Clinton discussed the challenge of improving healthcare in the developing and developed world as well as the role pharmacists can play in bringing this improvement about. More

Medication reconciliation critical to patient care, reducing medication mismanagement
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Medication reconciliation is a safety practice in which healthcare professionals review patients' medication regimens when patients transition between settings to reduce the likelihood of adverse drug effects. It is among the most complex clinical tasks required of physicians, nurses and pharmacists, who must work cooperatively to minimize discrepancies and inappropriate medication orders. Now, a University of Missouri gerontological nursing expert suggests that acknowledging practitioners' varying perspectives on the purpose of medication reconciliation and their roles in the process might increase implementation in healthcare institutions such as hospitals and nursing homes. More

 In the News


Antibiotic adherence in respiratory infections disappointingly low
Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Far more patients claimed to have adhered to their antibiotic prescriptions than actually did, according to the results of a study that used an electronic system to record when pill bottles were opened. Less than a third of patients who were prescribed antibiotics for respiratory infections demonstrated excellent adherence, and 4 in 10 of those who fell short of excellent adherence mistakenly reported that they never missed a dose, according to the results of a study published online in the International Journal of Infectious Diseases. More

FDA approves 1st epinephrine injection not for self-administration
American Society of Health-System Pharmacists    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Despite the availability of epinephrine injection for decades, no formulation in a container other than an autoinjector had FDA's approval until recently. On Dec. 7, FDA approved the new drug application from JHP Pharmaceuticals LLC for Adrenalin. More

Pharmacologists question aspirin resistance
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Aspirin resistance is an almost nonexistent phenomenon, one group of pharmacologists is claiming. In a study of 400 healthy individuals, they demonstrate that what appears to be "aspirin resistance" is simply due to the delayed release of the drug from an enteric-coated product. "The implications for patient care are that true aspirin resistance is really very rare, and, based on our study, we would not recommend routinely testing for aspirin resistance because the likelihood of finding it is small," the lead author told heartwire. More

 Medication Updates


New flu vaccine uses newer production method
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Flucelvax is the first seasonal flu vaccine to be approved by the Food and Drug Administration using a manufacturing method called cell culture technology, the agency said. Other flu vaccines are produced inside eggs. But that process takes longer than the newer method and could be harmful to people with egg allergies, the FDA explained. In cell culture technology, virus strains are grown inside mammalian animal cells. More

Pertuzumab for breast cancer cleared for EU approval
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Pertuzumab for breast cancer has just been given a go-ahead in the first step of the European approval process. The drug was given a positive opinion from the Committee of Medicinal Products for Human Use, which is a recommendation for marketing authorization. The next step is actual approval from the European Commission. More

Iclusig approved for rare leukemias
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Iclusig has been approved by the Food and Drug Administration to treat two rare forms of leukemia — cancers of the blood and bone marrow. The drug was sanctioned for adults with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia, the FDA said recently in a news release. More


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Dec. 11, 2012
Dec. 4, 2012
Nov. 27, 2012
Nov. 20, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063